Istradefylline improves daytime sleepiness in patients with Parkinson's disease: An open-label, 3-month study

Istradefylline improved daytime sleepiness in PD patients, possibly through its effect on enhancing alertness. In addition, the lack of significant changes in the total PDSS-2 scores over the study period suggests istradefylline had no negative impact on sleep.